A detailed history of Aia Group LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aia Group LTD holds 390,968 shares of EW stock, worth $25.6 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
390,968
Previous 492,969 20.69%
Holding current value
$25.6 Million
Previous $47.1 Million 23.34%
% of portfolio
1.1%
Previous 1.6%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$84.3 - $94.31 $8.6 Million - $9.62 Million
-102,001 Reduced 20.69%
390,968 $36.1 Million
Q1 2024

May 06, 2024

SELL
$72.54 - $95.56 $7.89 Million - $10.4 Million
-108,776 Reduced 18.08%
492,969 $47.1 Million
Q4 2023

Jan 31, 2024

BUY
$61.71 - $77.76 $8.3 Million - $10.5 Million
134,452 Added 28.77%
601,745 $45.9 Million
Q3 2023

Nov 01, 2023

BUY
$69.28 - $93.38 $5.29 Million - $7.13 Million
76,319 Added 19.52%
467,293 $32.4 Million
Q2 2023

Jul 28, 2023

SELL
$81.41 - $94.33 $5.88 Million - $6.81 Million
-72,237 Reduced 15.59%
390,974 $36.9 Million
Q1 2023

Apr 28, 2023

BUY
$74.26 - $84.51 $17 Million - $19.3 Million
228,272 Added 97.16%
463,211 $38.3 Million
Q4 2022

Jan 31, 2023

BUY
$68.3 - $87.44 $1.72 Million - $2.2 Million
25,131 Added 11.98%
234,939 $17.5 Million
Q3 2022

Nov 04, 2022

BUY
$82.37 - $107.29 $16.2 Million - $21.1 Million
196,330 Added 1456.67%
209,808 $17.3 Million
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $329,565 - $488,708
-3,810 Reduced 22.04%
13,478 $1.28 Million
Q1 2022

May 06, 2022

SELL
$101.96 - $128.34 $189,033 - $237,942
-1,854 Reduced 9.69%
17,288 $2.04 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $1.55 Million - $1.91 Million
14,582 Added 319.78%
19,142 $2.48 Million
Q3 2021

Nov 05, 2021

BUY
$102.91 - $122.75 $78,417 - $93,535
762 Added 20.06%
4,560 $516,000
Q2 2021

Aug 03, 2021

BUY
$83.84 - $104.76 $318,424 - $397,878
3,798 New
3,798 $391,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Aia Group LTD Portfolio

Follow Aia Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.